• Yotta Capital Partners led a private financing round backing Laboratoires Herbolistique, a French natural health supplements group, via a capital reorganization.
• The company sells more than 300 products to healthcare professionals, built on phytotherapy formulation expertise and a long-standing prescriber network.
• Yotta invested alongside Ouest Croissance as majority shareholders, with Bpifrance, Océan Participations, and management also participating.
• Proceeds target industrial scale-up, expansion of its CDMO manufacturing business, modernization of production, and bolt-on acquisitions.
• The transaction creates Groupe Nobilea, combining Laboratoires Herbolistique with contract manufacturers Vallée Nature and JRV.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Yotta Capital Partners SAS published the original content used to generate this news brief on July 30, 2026, and is solely responsible for the information contained therein.